46,XY DSD due to 17 beta-HSD3 Deficiency and 5 alpha-Reductase Type 2 Deficiency

Nenhuma Miniatura disponível
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER-VERLAG BERLIN
Citação
HORMONAL AND GENETIC BASIS OF SEXUAL DIFFERENTIATION DISORDERS AND HOT TOPICS IN ENDOCRINOLOGY, v.707, p.9-14, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Palavras-chave
Referências
  1. ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0
  2. Lee YS, 2007, CLIN ENDOCRINOL, V67, P20, DOI 10.1111/j.1365-2265.2007.02829.x
  3. Andersson S, 1997, STEROIDS, V62, P143, DOI 10.1016/S0039-128X(96)00173-0
  4. THIGPEN AE, 1992, J CLIN INVEST, V90, P799, DOI 10.1172/JCI115954
  5. Hughes IA, 2006, ARCH DIS CHILD, V91, P554, DOI 10.1136/adc.2006.098319
  6. Andersson S, 1996, J CLIN ENDOCR METAB, V81, P130, DOI 10.1210/jc.81.1.130
  7. Mendonca BB, 2009, CLIN ENDOCRINOL, V70, P173, DOI [10.1111/j.1365-2265.2008.03392.x, 10.1111/j.1365-2265.2008.03492.x]
  8. THIGPEN AE, 1993, J CLIN INVEST, V92, P903, DOI 10.1172/JCI116665
  9. Mendonca BB, 1996, MEDICINE, V75, P64, DOI 10.1097/00005792-199603000-00003
  10. Cohen-Kettenis PT, 2005, ARCH SEX BEHAV, V34, P399, DOI 10.1007/s10508-005-4339-4
  11. RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.biochem.63.1.25
  12. Mendonca BB, 2000, MEDICINE, V79, P299, DOI 10.1097/00005792-200009000-00003
  13. WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577
  14. Bertelloni S, 2006, GYNECOL ENDOCRINOL, V22, P488, DOI 10.1080/09513590600921358
  15. Chavez B, 2000, J CLIN ENDOCR METAB, V85, P3147, DOI 10.1210/jc.85.9.3147
  16. Griffin J. E., 2001, METABOLIC MOL BASES, V3, P4117
  17. Imperato-McGinley J, 1997, Curr Ther Endocrinol Metab, V6, P384
  18. IMPERATOMCGINLEY J, 1985, J CLIN ENDOCR METAB, V60, P553
  19. IMPERATOMCGINLEY J, 1991, CLIN ENDOCRINOL, V34, P293, DOI 10.1111/j.1365-2265.1991.tb03769.x
  20. IMPERATOMCGINLEY J, 1979, NEW ENGL J MED, V300, P1233, DOI 10.1056/NEJM197905313002201
  21. IMPERATOMCGINLEY J, 1979, J CLIN ENDOCR METAB, V49, P391
  22. IMPERATO.J, 1974, SCIENCE, V186, P1213, DOI 10.1126/science.186.4170.1213
  23. Mendonca BB, 2003, ENDOCRINOLOGIST, V13, P201
  24. Mendonca BB, 1999, J CLIN ENDOCR METAB, V84, P802, DOI 10.1210/jc.84.2.802
  25. ROSLER A, 1983, J STEROID BIOCHEM, V19, P663, DOI 10.1016/0022-4731(83)90233-9
  26. Rosler A, 1996, J CLIN ENDOCR METAB, V81, P1827, DOI 10.1210/jc.81.5.1827
  27. SAEZ JM, 1971, J CLIN ENDOCR METAB, V32, P604
  28. WIGLEY WC, 1994, BIOCHEMISTRY-US, V33, P1265, DOI 10.1021/bi00171a029
  29. Wilson JD, 2001, HORM BEHAV, V40, P358, DOI 10.1006/hbeh.2001.1684
  30. Wisniewski AB, 2009, INT J PEDIAT ENDOCRI, V2009, DOI 10.1155/2009/567430